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Highlights 
 
● Little attention has been given to the role of nonapeptides in early human sociability  
● Evidence is suggestive of their contribution to different dimensions of normal and 
pathological socio-affective functioning  
● The field may benefit from standardization of procedures and techniques 
● Differences between life stages may exist and should be described 
● This knowledge may inform drug development in paediatric populations 
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Abstract  
 
The hypothalamic nonapeptides oxytocin and vasopressin are important modulators of 
socio-affective behaviours in a wide variety of animal species, including humans. Nevertheless, 
there is little research addressing their possible roles on socio-affective dimensions of human 
behaviour across development, during which considerable behavioural and physiological 
change occurs. Questions still remain about the extent to which findings from adults may 
directly apply to earlier phases of human development. In this article, we systematically 
summarize and discuss all existing studies investigating the developmental association of 
endogenous levels of hypothalamic neuropeptides oxytocin and vasopressin with human social 
behaviour or on its disruption in paediatric populations. Evidence is sparse insofar as there are 
still relatively few developmental studies and limited due to correlational research designs and 
unreliability of methods currently used for neuropeptide measurements in biological fluids. The 
findings to date generally converge with adult evidence, but also suggest that important 
differences between age stages may exist. Further studies focusing these differences may 
prove critical for informing drug development for socio-affective deficits in paediatric 
populations.  
 
Key-Words: oxytocin; vasopressin; social cognition; paediatric populations; neurodevelopment 
disorders; autism 
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1. INTRODUCTION 
 
Even after decades of research, the two nine-amino-acid hypothalamic neuropeptides, 
oxytocin (OT) and vasopressin (AVP), continue to capture the attention and fuel scientific 
curiosity of diverse fields: from neurobiology to the social sciences. Many studies from different 
areas of knowledge have supported the notion that, along with their well-known functions in 
labour, breastfeeding and/or water balance, these hypothalamic nonapeptides have evolved as 
important modulators of socio-affective behaviours in a wide variety of animal species, 
including humans(1-3). Indeed, a wealth of evidence from animal models’ studies has 
demonstrated their modulation of adult social behaviour, including social recognition(4), 
maternal behaviour(5), social bonding(6, 7), communication(8) and aggression(9). Joining this 
evidence, a flood of studies in humans has implicated these neuropeptides in human adult 
socio-affective behaviour, including, but not limited to, generosity, cooperation, visual attention 
to social stimuli, regulation of negative affect processing, social learning (for an extensive 
review see(10, 11)). However, despite popular assumptions that these neuropeptides are 
critical elements of human social behaviour in youth, including social bonding during infancy, 
their role in childhood and adolescence - when considerable changes in behaviour and 
physiology occur(12) - has received considerably less attention from researchers. Most studies 
reported to date, both in human and non-human animals, have used adult samples.  
Social competence in adulthood stems from social learning during development(13, 
14). Indeed, sociality is a highly dynamic dimension of human behaviour, characterized by 
intense changes during psycho-emotional ontogenesis(15): e.g. an increase in social network 
complexity, the emergence of a social-self, the development of perspective-taking, an increase 
in the regulation of emotional behaviour, among others(15, 16). These behavioural changes 
are accompanied by pronounced and prolonged structural modifications in several brain 
regions implicated in social cognition, namely parts of prefrontal, parietal and superior temporal 
cortices(16). Although already present in the prenatal developing brain, preclinical evidence 
suggests that the expression of the receptors of AVP (arginine vasopressin receptor 1A 
[V1aR]) and OT (oxytocin receptor [OTR]) change quantitatively and topologically during pre- 
and post-natal development(17-20). Their distribution patterns in the brain depend on age and 
species, with quantitative levels being modulated by gonadal hormones and experience. 
Changes in OTR and V1aR expression during pre- and post-natal human brain development 
seem to exist as well. Data from the Human Brain Transcriptome project (http://hbatlas.org) 
indicate that, for instance, V1aR mRNA expression peaks in the human neocortex during the 
second trimester of prenatal development, then slowly decays through the rest of the pre- and 
post-natal life. Human OTR expression seems to be high at birth and for the first 3 years in the 
neocortex, with prolonged expression in the medial prefrontal cortex. Less is known about the 
developmental trajectories of expression for CD38 and Leucyl And Cystinyl Aminopeptidase 
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(LNPEP), a molecular player involved in OT release(21) and one of the enzymes responsible 
for both OT and AVP degradation(22). Considering that, at least in the brain, several elements 
of these nonapeptides’ machinery seem to dynamically evolve during the post-natal period, 
one may speculate these changes are functionally relevant and underpin significant 
differences between OT/AVP impacts on behaviour during different developmental periods. 
Unravelling the intricacies behind OT and AVP biology during early-ages and their implications 
for the development of several socio-affective dimensions of behaviour may represent a critical 
step toward a better understanding of the role of these peptides play in the regulation of social 
behaviour and/or its disruption during illness. Moreover, both OT and AVP activity in early-life 
have a long-term impact on the brain and behaviour(21). A full understanding of the 
neurobiological mechanisms underpinning social behaviour must, therefore, include a 
complete and detailed characterization of the biological and neural circuits underlying socio-
emotional changes during development. 
Studies in young non-human animals have been critical for identifying the causal 
implications of OT and AVP in social behaviour during infancy and childhood(19). Direct 
manipulation of OT/AVP and/or their receptors (pharmacological and genetic editing) has an 
effect on processes involved in early-life sociality, including parental engagement(23), 
familiarity preferences(24), distress vocalization during separation (25) or social contact 
between neonates(26). Moreover, in animal models single and chronic manipulations of OT in 
the perinatal period have affected sex-specific adult sexual preferences and brain 
neurochemistry (for a comprehensive review of the preclinical evidence in early ages see(19) 
and (27)). Although few in number, these studies converge to show that exposure to these 
peptides during critical periods of post-natal development may induce permanent changes in 
the organization of their signalling machinery in several areas of the brain and in behaviour. 
Moreover, these changes seem to persist through adult-life(28). Additionally, some studies 
have shown early experience may itself impact on the development of OT and AVP 
biology(28).  
Although similarities in social behaviour exist between human and non-human animals 
(including the neonatal, childhood and adolescence periods), human behaviour is naturally 
intricate and accompanied by some particularities (for instance, while rodent social behaviour 
strongly relies on olfactory cues, humans mostly rely on visual and auditory cues(29)). 
Moreover, species-related specificities have been described in terms of hypothalamic 
nonapeptides physiology(30). As for other animals, a full understanding of the biological 
mechanisms underpinning human social behaviour must include a complete and detailed 
characterization of the biological circuits underlying socio-emotional development across the 
life span during development(31). Building on this assumption, an increasing wave of studies 
have tried to uncover the role of OT and AVP in socio-emotional behaviour in paediatric ages 
and examine the extent to which findings in young non-human animals may be applied to 
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humans (Fig.1). Contributing to the urgency of this field is the fact that one of the most 
promising proposed applications of these molecules as drug therapies are the 
neurodevelopmental disorders, such as the autism spectrum disorders, which typically affect 
paediatric populations(32). A better understanding of the contributions of these peptides to 
socio-affective processing early in life may be critically important for directing therapeutic 
advances in these age periods. 
 Traditionally, human research on hypothalamic nonapeptides relies on 1) acute 
pharmacological manipulation of OT and AVP through intranasal administration; 2) correlative 
studies of OT and AVP measurements in peripheral fluids with socio-emotional phenotypes; 3) 
behavioural and imaging genetic association studies of OT and AVP related polymorphisms 
with socio-emotional behaviour and its related brain underpinnings. It is not surprising that the 
intervention profile of the experimentally controlled pharmacological designs positions this 
approach at the leading edge of research designed to discover the role of hypothalamic 
nonapeptides in human behaviour. However, the ethical questions associated with 
pharmacological studies in paediatric ages have precluded its expansion to these ages(33). 
For this reason, research has mostly relied on attempts to establish associations between 
measurements of these peptides in peripheral biological fluids and behavioural/brain 
phenotypes.  
In order to facilitate an objective overview of such findings, we systematically 
summarize and discuss all existing studies that have investigated the role of the hypothalamic 
neuropeptides OT and AVP in human social behaviour or on its disruption during childhood 
and adolescence. We understand that there are limitations associated with the peripheral 
measurements of these peptides used in most of the existing studies (such as the use of 
peripheral surrogate nonapeptide levels, whose ability to index central hypothalamic 
nonapeptides has been subject to intense criticism(34) and the uncertainties about how these 
measures in different biological fluids correlate between each other(35)). We highlight and 
discuss the potential issues and limitations that may be critical to a comprehensive 
interpretation of these findings. The reviewed findings are discussed in light of existing animal 
knowledge and coordinated with the current mechanistic frameworks of OT/AVP roles in 
human social cognition, affective processing or psychopathology. We hope our review will 
serve to: 1) summarize suggestive evidence from studies early in life that may inform further 
intervention studies in paediatric populations; 2) increase awareness of the importance of 
further research on the role of nonapeptides in emotional-social development during paediatric 
ages and its importance for translational research; and 3) help researchers identify pertinent 
questions that may speed advances in the field. 
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2. METHODS 
2.1. Search strategy 
 
We followed the PRISMA guidelines for systematic reviews to identify relevant studies 
for inclusion in the current review (Figure 2). A search in Medline was performed to identify all 
studies examining associations between OT and/or AVP endogenous levels and socio-
emotional behaviour and/or psychopathology in infants, children, and/or adolescents using the 
query: ("oxytocin" OR "vasopressin") AND ("children" OR "infant" OR "adolescents" OR "pre-
adolescents" OR "youth") AND ("social" OR "emotional" OR “affective” OR "disorder"). All 
references in the retrieved articles were also manually checked to detect any previously 
missed articles. Duplicated studies were removed using ENDNOTE smart group function. 
2.2. Selection criteria 
Inclusion and exclusion criteria were tailored to obtain all studies, published up to 7th 
of March of 2017 (irrespective of publication date and subjects’ age, sex or ethnicity), which 
were original reports on the association between endogenous levels of OT and/or AVP 
socioemotional behaviour and/or psychopathology. One report published between the end 
date of our searching and this manuscript revision was included as an additional record. 
Reports also had to be written in English, available in full-text and published in a peer-reviewed 
journal. Exclusion criteria were: being a review or meta-analysis, non-English written, non-peer 
reviewed or a proceedings publication, or animal study, or a registered study’s protocol, or 
studies with adults, or genetics association studies without assessments of OT/AVP levels or 
studies not focusing on socio-emotional behaviour or psychopathology. 
2.3. Systematic review 
For each retrieved study, the following variables were recorded: aim; number, sex and 
age of participants; methods used for OT/AVP measurements; conditions where biological 
sampling occurred; instruments/paradigms/stimuli used for evaluating socio-emotional 
behaviour and/or psychopathology; main findings. For the studies conducted in clinical 
samples, additional information about the diagnosis and the sample size of cases and controls 
were also retrieved. For simplicity, core findings are then presented and discussed in 5 
separate sections, namely: 1) Studies with infants; 2) Studies with pre-school and school 
children; 3) Studies with pre-adolescents and adolescents; 4) Studies with children after 
adverse early-life environment; 4) Studies with clinical populations (Autistic Spectrum 
Disorders (ASD), and others). 
2.4. Quality assessment 
Each study was appraised on a 12-quality requirement score list (detailed in Table 1). 
For this, information was retrieved from the main article or online supplementary material. For 
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each item, a score of 0–3 was attributed dependent on whether there was strong (3), some (2), 
little (1) or no evidence (0) that it was adhered to. The sum of the 12 items’ scores, divided by 
the maximum sum applicable to the respective study modality, was then used as an indication 
of the general quality of the study (low: ≤69%, medium: 70–90%, high: ≥90%). No study was 
discarded on the basis of a poor general quality score. 
 
 3. RESULTS 
3.1 Overview 
 
A total of 45 studies (which were published over the past 24 years) were reviewed. 
From these, 5 studies were conducted with infants; 3 in pre-school and school children; 4 in 
pre- and adolescents; 3 in post-institutionalized and maltreated children; and 29 in clinical 
samples, spanning ASD, Attention Deficit Hyperactivity Disorder (ADHD), Obsessive 
Compulsive Disorder (OCD), depression, anxiety, conduct disorders and Prader-Willi 
syndrome.  
Summarized descriptions of each study core findings are presented in tables 2, 3, 4, 5 
and 6. 
The methodology and the target population of the identified studies varied considerably 
(for an overview see Fig 3). The studies’ populations included neonates, babies, children, pre- 
and adolescents but also participant’s parents or other caregivers. Moreover, while some 
studies focused on the application of validated psychological instruments destined to evaluate 
socioemotional behaviour or psychopathology, others focused on controlled lab-based 
paradigms or ecological evaluation of child-parents’ interactions. There is considerable 
heterogeneity in methodological approaches across studies: in the time interval spanned by 
the measurement, in the type of biological fluids chosen for analysing neuropeptides’ levels, 
spanning plasma, urine, saliva and cerebrospinal fluid, in the method used for sample 
collection and in the assay techniques used for neuropeptide measurements (including the use 
of both extracted and unextracted samples; ELISA and RIA techniques), which makes absolute 
comparisons difficult and precludes meta-analytic synthesis of the core findings.  
 
3.2. Quality assessment 
 
There were 13 studies scoring “High”, 31 studies scoring “Medium” and 1 study scoring 
“Low”. An overview of the studies’ compliance with our criteria is presented in Table 1. 
 
 AC
CE
PT
ED
 M
AN
US
CR
IPT
  
 9  
4. DISCUSSION 
4.1 General discussion 
 
The majority of studies we review herein were “moderate” quality. The most common 
factors which resulted in a medium quality rating were as follows: the low effort to include 
important demographic and neuropsychological variables in data collection and analysis, the 
poor description of participant’s inclusion and exclusion criteria, or of the study’s a priori 
hypothesis (including direction of main effects and interactions), the small sample sizes and 
the poor description of the fluid sampling conditions and neuropeptides’ measurements 
protocol. 
Overall, although increasing over the past years, the studies investigating the role of the 
hypothalamic nonapeptides OT and AVP in socio-emotional behaviour during childhood and 
adolescence are still scarce in number. Possible explanations may include the methodological 
and ethical challenges inherent to the research on paediatric populations(33). A significantly 
higher focus has been made on OT research, possibly due to well-grounded preclinical 
evidence supporting its role in motherhood and mother-infant interaction(36), with only a few 
studies (22% of all reviewed) focusing on AVP. This is surprising given the preclinical research 
supporting the role of AVP in social cognition during early-life as well. Importantly, such 
findings suggest that AVP may counteract OT actions in ‘primordial’ social behaviour, such as 
maternal separation distress vocalizations and early social odour learning(19), e.g. while OT 
levels correlated positively with increased maternal separation distress, AVP tended to 
correlate negatively. Some of the current working hypotheses suggest AVP, acting centrally 
may elevate vigilance and defensiveness, possibly serving in some cases as an antagonist to 
the effects of OT — and vice-versa. Conversely, OT may have the capacity to reduce fear and 
calm the sympathetic responses to stressful stimuli, including those associated with social 
behaviour(37). In adults, the exact relationship between OT and AVP actions in social 
behaviour is not yet clear (but some studies suggest that both peptides may act on the same 
direction to promote sociality)(37).  
This research has been particularly biased towards ASD (47% of the total studies 
herein reviewed). This focus may reflect efforts to explore its putative role in the 
physiopathology of these disorders in order to inform their suggested use as an adjunctive 
targeted pharmacological treatment (namely in ASD, where the vast majority of preliminary 
clinical trials of intranasal OT have been performed(38)).  
Limitations common to the vast majority of the studies here reviewed derive mainly 
from: 1) the use of correlational designs in all studies, which limits the possibility to establish 
causality and reduces the impact of the evidence gathered(39); 2) the use of peripheral 
surrogate nonapeptide levels, whose ability to index central hypothalamic nonapeptides has 
been subject to intense criticism(34); and 3) the use of methods of sample processing and 
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peptide quantifications whose specificity remains under debate (namely concerning the use of 
extracted vs unextracted samples and/or the use of ELISA vs RIA techniques)(35)  – which is 
discussed below; 3) the small sample sizes recruited for the bulk of the studies, which raises 
important questions about the actual statistical power achieved (particularly when the reliability 
of these measures is as yet unknown).  
Peripheral concentrations of OT and AVP (in plasma, urine and saliva) have been 
used as a proxy for central concentrations. However, the validity of this approach has not been 
demonstrated. A recent systematic search and meta-analysis of correlations between central 
and peripheral OT concentrations found a modest positive association. However, this 
association seem to be restricted to measurements after intranasal OT administration or after 
experimentally induced stress, i.e. not between baseline levels(34). Regarding the inference of 
central nonapeptide levels, we note that OT and AVP release in deep brain tissue may not 
accurately be reflected even in the measured levels at the CSF (and the same applies for 
peripheral measurements such as blood, saliva or urine). In contrast with more primitive 
species where OT and AVP transmission derives mainly from diffusion through the CSF in the 
ventricular system, a controlled axonal synaptic release of these neuropeptides has been 
described in higher species (for instance rodents) and is likely applicable to the human 
brain(27). In fact, some studies suggest now that, the release of central and peripheral OT may 
be dissociated and involve different signalling mechanisms(40) and/or sub-anatomical 
pathways(41). At this point in time, it is not clear whether saliva, plasma and urine levels of OT 
do really correlate positively with each other(34).  
It is also unclear whether the potential biological interpretations of these measures in 
each of these fluids might be and which potential mechanisms link them to behaviour or brain 
function. In fact, their use has been grounded on the assumption they may indeed reflect inter-
individual differences in OT/AVP physiology, namely their secretion and signalling in the brain. 
A recent study aiming to biologically validate OT measurements in saliva and urine in primates 
suggested that 1) urinary OT measurements may be suitable for establishing baseline levels, 
as they may represent the build-up of the previous day's concentrations, and 2) salivary OT 
measurements may be suitable for assessing changes following specific events(42). It is 
possible that similar conclusions might be observed for humans, but current evidence is 
insufficient to support such conclusions. Additionally, if this is the case, it is also not clear 
which fluid may better index, for example, OT/AVP secretion or in which fluid inter-individual 
differences in these measures may be more strongly affected by differences in metabolism. 
For instance, while the acidic environment of urine may help to preserve these small peptides, 
the presence of degrading enzymes in blood are likely to promptly metabolize them(43).These 
aspects pose important limitations to the critical interpretation of bio-behavioural studies such 
as those discussed in the current review. A comprehensive evaluation of the validity of these 
measures, including an assessment of their temporal reliability and the ability of single-
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measurements to represent individual nonapeptides’ basal physiology, is sorely needed. As 
soon as this information can be gathered, a richer and complete analysis of the findings 
already achieved will be possible. 
The validity of the techniques for quantifying neuropeptides has been one of the most 
pressing questions in the field, since accurate determination of OT levels is crucial to motivate, 
support, and inform research (particularly in paediatric ages) and clinical interventions(35). We 
stress that, for now, no simple answer to this question exists. Some studies suggest the use of 
unextracted samples lack reliability and likely target other molecules than OT, namely 
degraded forms of the peptide lacking functional relevance(44) and other recent studies 
applying a standard proteomic method of peptide identification and quantification, mass 
spectrometry, suggest that biological fluid extraction may discard a significant proportion of the 
total fraction of OT, corresponding to the amount of peptide linked to large proteins(45). If so, 
aspects such as the biological significance of bound OT, as well as the importance of the 
exchange rate between bound and unbound peptide, should be clarified. One study also 
suggested that RIA quantification may not be sensitive enough to detect OT concentrations 
both in extracted and non-extracted plasma samples(44), raising concerns about the common 
assumption that this method should be used as gold standard. More recently, the liquid-
chromatography mass spectrometry approach has been apointed as a potential standard 
method for peptide measurement in biological fluids (45, 46). Despite this recent 
recommendation, none of the most recent reviewed studies made use of this technique. 
We cannot exclude the possibility that, similar to the results observed for intranasal OT 
research, significant publication bias may exist. This has been a prominent question in the field 
and effort has been recently made to minimize reporting bias through an intense incentive to 
pre-register studies. We note that despite of this current intense discussion, none of the 
reviewed studies have implemented this procedure.  
Bearing these limitations in mind, below we separately discuss the studies here 
reviewed, contextualizing the findings achieved in terms of the current theories evoked to 
explain the role of OT and AVP in socio-emotional behaviour and establishing, as much as 
possible, the parallel with preclinical studies addressing similar questions.    
 
4.2 Infants  
 
Overall, the studies reviewed in this section are generally compatible with the notion 
that already in the first months of life, the OTergic system is: 1) active in human infants; 2) 
measurable; and 3) reacts to social contact in a predictable way. Moreover, the findings 
achieved support current theories suggesting that social engagement during the first months of 
life may be supported by the OTergic system, which may drive affiliative and attachment 
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behaviours in early social life(47). Indeed, the infant OT system seems to react to episodes of 
interaction with parents(48); remarkably, OT variations are correlated between infants and 
fathers and predict parent-child behavioural synchrony(48). This relates well with behavioural 
and neuroimaging inter-subject correlation studies in adult males, suggesting OT increases 
inter-personal social coordination via increasing the synchrony of brain activity(49, 50)). These 
observations are consistent with animal research showing that OT (versus an OT antagonist) 
administration increases social contact cohesion among dam and pups(51). At the same time, 
they also align with recent findings, suggesting OT may participate in interspecific attachment 
behaviour, such as those observed between domestic dogs and their human owners (52, 53). 
Children with higher CSF OT levels appear to more actively seek parental social 
interaction for soothing and have a greater interest in social interaction as measured at 6 
months of age(54). The only exception to these working hypotheses resides in one study 
developed in hospitalized premature infants which reported a negative correlation between 
infant OT levels and social engagement(55). While discordant with all other findings of this 
section, one should not forget that this study targeted a special infant population characterized 
as clinically concerning and submitted to high physiological demands to maintain organic 
homeostasis. In fact, social engagement was mainly quantified during breastfeeding and it is a 
possible scenario that the premature infants have blocked any extraneous stimuli, such as 
stimuli from maternal social engagement behaviours, in an effort to maintain physiologic 
equilibrium during feeding(56, 57). Apparent mixed results regarding the association of OT 
levels with infant crying are presented as well. While in infants submitted to maternal massage, 
lower OT levels were associated with increased crying(58), in another study, higher levels of 
OT were associated with higher crying when parents were not present(54). We speculate that 
the critical contextual aspect justifying these differences is the parents’ presence and 
availability. Previous animal research showed that central administration of OT reduces the 
frequency of isolation-induced distress vocalizations in pups and chicks(59). It is reasonable to 
hypothesize that, when parents are in the vicinity and readily available, the release of higher 
amounts of OT – possibly naturally evoked by the parents’ presence - may happen to reduce 
stress and the amount of crying (assuming that crying represents a distress vocalization), 
functioning then as a social buffer. This hypothesis is in agreement with current theories 
evoked to explain the stress attenuating effects of intranasal OT when a conspecific is present, 
in adults(60). Conversely, when parents are not available, release of OT may occur to promote 
parental seeking, expressed through crying vocalization, acting, thus, as a motivational system 
designed to reduce stress through affiliation. This theory is supported by evidence in adults, 
suggesting that stress may increase OT release and may constitute a physiological fingerprint 
of the “tend-and-befriend” strategy of coping with stress(61, 62). The mechanisms responsible 
for parental detection that may be relevant to activate the OT system remain however to clarify. 
One may speculate during this early stage affective touch and C-tactile stimulation in the skin 
may be particularly relevant. Indeed, previous research has shown that low intensity, non-
noxious, stimulation of cutaneous somatosensory nerves triggers OT release and is 
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associated with increased social motivation, plus reduced physiological and behavioural 
reactivity to stressors(63, 64).  
The two studies examining correlations between children and parents’ OT responses 
converge to support the hypothesis that OT physiology may be transmitted cross-generation 
between parents and children, probably via explicit parental behaviour(48). One of these 
studies also demonstrated that intranasal OT intervention in the father is accompanied by 
increased OT infant’s responses to parent-child interaction(65). OT-driven parental responses 
may, thus, interact with other contextual factors to shape infants’ OTergic responses to social 
stimuli(48). 
 We also highlight that the only study comparing male and female infants’ levels of 
baseline salivary OT did not find any significant differences (48). This study aligns with some 
adult studies aiming to inspect if nonapeptides levels measured in different biological fluids 
may vary between males and females and from where no convincing evidence could be 
gathered so far. However, no study to date has thoroughly compared plasma, CSF or urine 
levels of OT or AVP between sexes during infancy. Sex differences in OTergic tonus, as well 
as its potential involvement in sexual dimorphic infants’ socio-emotional behaviour, remain thus 
to be tested.  
Studies examining relationships between AVP and socio-emotional behaviour at these 
neurodevelopmental stages were non-existent. 
 
4.3 Preschool and school children 
 
Despite heterogeneity in the aspects of the socio-emotional behaviour that were 
targeted, the reviewed studies with children at pre-school and school ages were very much in 
agreement to support a positive association of OT with: 1) positive social relationships and 
engagement both with parents(66); 2) generosity(67); and 3) visual attention to social 
cues(68). Indeed, salivary OT was found to be associated with child best-friend social 
reciprocity, defined as give-and-receive interactions, adaptation to each other's needs, 
communications, requests and engagement in shared activity(66). This result is congruent with 
research in rhesus monkeys describing an association between central OT levels at 18 months 
and the expression of affiliative social behaviour with peers including allo-grooming, sitting in 
contact, clinging, and touching(69). Nevertheless, one study examining the association 
between salivary OT and generosity at these ages suggested that, similar to observations of 
adult monkeys(70), some degree of sexual dimorphism may exist regarding, at least, the 
association between OT and generosity: the association between OT and generosity tends to 
be stronger for girls than boys(67). Thus separate analyses by sex are needed to more fully 
characterize the role of OT socio-emotional behaviour and related neurocorrelates during 
childhood and adolescence. The results (at least for girls) are generically consistent with 
current theories, suggesting that OT may be involved in human in-group favouritism(71-73), an 
association that seems to be present already during childhood. 
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Regarding attention to social cues, a positive and a negative association between 
salivary OT levels and fixation time in the eyes or in the mouth during exploration of a human 
face, respectively, was found in one study(68). This observation is much in agreement with 
pharmacological studies of OT in healthy and ASD adults showing that OT potentiation 
increases visual fixation, facial element critical for social interaction and communication, for 
example, mutual gaze(74). These findings support one of the most cited theories to explain 
OT’s actions in social cognition, the social salience hypothesis, which suggests that OT may 
have evolved to amplify the salience of social cues(75).  
We identified one study that reported a decrease in salivary(68) OT levels with age, in 
childhood. We were not able to find any studies examining relationships between AVP and 
socio-emotional behaviour during infancy of childhood. 
4.4 Pre-adolescents and adolescents 
The four studies reviewed in this section were mostly developed to examine 
associations between endogenous OT and negative affect regulation(61, 76-79) through social 
physical comfort. Relevant observations included an increase in urinary OT in children/pre-
adolescents who are comforted by their mothers with direct physical contact after a stressful 
test situation. This result is in accordance with animal research showing skin-to-skin contact 
between mother and pup are positively correlated with the pups’ hypothalamic OT 
concentrations(80). However, the fact that OT levels did not change overall for children who 
rested alone or received no maternal comforting following the stressor is in contrast with 
findings in adults, that suggest physical and psycho-social stress per se may elicit OT 
release(62). In terms of mode of comforting, OT increase was similar in physical-tactile and 
voice-only comforting(76), as seen in other mammals, but was not observed when “contact” 
was assessed as instant messaging(78). This suggests cognitive perception of a comforting 
message is not enough to elicit OT release. Another study in adolescents replicated the effect 
on OT when comfort comes from parents but not when from best-friends (particularly for 
males); contrarily to expectation, these results suggest that friends do not take over the 
parental social buffering role by age 15-16, at least for males(61). Although a single and not 
yet replicated finding, this study suggest that parental support is critical to regulate OT’s 
response to stress, even in adolescence, when peers have increasingly salient roles in social 
life. Specific parental support effects in stress-induced OT release may, therefore, represent a 
conserved biological mechanism, evident early in life, by which parental attention and contact 
may help to regulate negative affect years later (at least until adolescence). One study found 
that CSF and plasma OT correlate negatively with parental reports of anxiety, supporting 
current theories that suggest OT may reduce anxiety and thereby influence social behaviour. 
Interestingly, this study reported that although CSF OT’s concentrations are significantly higher 
than in plasma, they are positively correlated at a medium effect size(79). While further 
replication studies are needed to confirm the utility of plasma measurements as surrogates of 
CSF OT concentrations, for now there is no reason to believe that, at least at these age 
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periods, the same inconsistencies found in adults regarding the associations between 
peripheral and CSF measurements may apply. Further studies examining this question will be 
welcomed. 
Physiology-wise, one study reported a decrease in urinary(61) OT levels with age, in 
adolescents when compared to pre-adolescents. Moreover, the same study reported lower 
levels of urinary OT in males than in females. This observation supports the idea that there 
may be significant sex differences in OT baseline at multiple points in development. OT has 
been associated with more prosocial, passive coping strategies in the face of stress, which 
some authors suggest may be directly related to sex differences in coping strategies between 
men and women (e.g., tend and befriend vs. fight or flight)(81). This notion is partially 
supported in this study by the finding that while urinary OT levels decreased in face of a 
stressful challenge in boys when they were paired with friends, this effect was not observed in 
females. This observation suggests that OT may indeed have a major role in female regulation 
of negative affect through affiliative bonds. However, we should not lose sight of the fact that 
consistent evidence of significant differences on OT production and signalling in adults have 
not been reported to date(82).  
Studies examining a relationship between AVP and socio-emotional behaviour at 
these age stages were not found. 
 
4.5 Adverse early-life environment 
 
The four studies reprised in this section converge to show that early-life environment, 
in the form of children’s institutionalization, maltreatment or parental depression/distress, 
influences hypothalamic nonapeptides’s physiology for children. Reports include basal and 
stimuli-induced atypical responses of both OT and AVP systems. One study showed that, even 
for similar baseline levels, adopted children that had been neglected in orphanages had lower 
urinary OT levels after interaction with their adoptive mothers than family-reared children. In 
contrast, while adopted children presented lower levels of basal AVP, these children did not 
differ from controls in social interaction-induced variation AVP(83). These results are congruent 
with animal research showing that naturally occurring variations in quality of maternal care are 
associated with OT functioning in the youth(80, 84) or that early deprivation of contact with the 
mother in primates and rodents caused reduction of central OT levels across development(85-
87). 
Complementing these findings, mother’s chronic depression and father’s distress were 
concomitantly associated with a decrease in salivary OT both for children and parents(88). 
These findings are consistent with the hypothesis OT physiology can be transmitted across 
generations and may reflect a decrease in explicit parental affiliative behaviours during 
depression. Overall, this study highlights the importance of early-intervention during parental 
depression in order to prevent long-term effects on children’s nonapeptides physiology. 
Potential therapeutic strategies may include intranasal OT augmentation for the parents. 
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Additionally, preclinical studies suggested that OT augmentation during adulthood in animals 
previously subjected to neglect in early life may remediate some of the socio-affective deficits 
present in these animals(89). Similar studies in humans are lacking, data from such studies 
may help pave the way for targeted therapies aiming at improving socio-affective functioning 
after early adverse experience. Interestingly, and contrary findings came from two studies 
showing that increased salivary OT was found both in: 1) children reared in settled 
environments after an early-period of maltreatment (interestingly, not observed in those reared 
in unsettled environments) (90); and 2) girls who have experienced early childhood 
maltreatment, including an atypically high OT response to a social stressor(77). These findings 
are compatible with a series of studies showing increased OT responses in female prairie 
voles after an acute stressor(91). In humans, salivary OT also increased in response to 
physical or psychosocial stressors, for both females and males(62). Current theories suggest 
that mammals deal with stressful experiences by seeking social support, which seems to be 
especially adaptive for females(92, 93). Nevertheless, we note that the collective analysis of 
the studies published until now does not permit drawing clear inferences about the effects of 
early care neglect on responsiveness of the OT system during adulthood. In fact, while sexual 
dimorphic response to early life stress may underpin the apparent disparate findings presented 
in the studies included in this section, it is not yet clear whether early life stress results in an 
attenuation or in an over-activation of OT secretion - both chronic or acute after a stressful 
event - and if these effects are significantly different between males and females.  
While attenuation as an outcome would be easily reconciled with the increased 
incidence of social deficits observed in these populations, over-activation could reflect a 
compensatory mechanism circumventing an epigenetic attenuation of signalling at the 
receptors level. Indeed, recent work has demonstrated that low maternal care is associated 
with increased OT receptor promoter methylation levels, a process which typically represses 
gene expression(94). Consistent with these findings, another recent study reported a decrease 
in the expression of OT receptor in peripheral blood cells of mothers maltreated during 
childhood, although no differences could be identified in baseline plasmatic OT between 
maltreated and non-maltreated individuals(95). For maltreated mothers, expression of OT 
receptors correlated negatively with Childhood Trauma scores(95). Dynamic changes in OT 
receptor methylation in response to psychosocial stress have been reported as well(96, 97). 
The mechanisms behind these associations between early maternal care and increased OT 
receptor methylation/decreased receptor expression in adulthood remain to be determined. It is 
possible that persistent elevation of stress-related molecules associated with maternal care 
deprivation induce persistent epigenetic phenomena regulating nonapeptides’ genes that may 
act to shape OT responses later in life. Further studies will be critical to illuminate these 
questions and prompt new targeted early-interventions to prevent/minimize deleterious effects 
of early care neglect on children’s functioning.   
 
4.6 Clinical samples 
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4.6.1 Autism spectrum disorders 
 
There is mixed evidence regarding the hypothesis of nonapeptide deficiencies in ASD, 
even though it tends to be supportive. While 8 studies support the hypothesis that ASD 
patients present lower levels of OT than typically developing controls, no difference was seen 
in 5 studies, and 2 others found the opposite association. Studies diverge considerably in the 
types of biological sample used to assess nonapeptide levels, conditions of assessment 
(namely in respect to the time of the day when sample was collected, the presence of fasting), 
the approach used for sample collection (that is, the use of RIA vs ELISA), and extracted vs 
unextracted samples. All of these factors have been shown to affect OT and AVP 
measurements and may, at least partially, explain the disparate results reported (35). Also, in 
at least one study reporting no difference, the sample size is quite small, which may have 
limited power to detect small but meanignful differences. Nevertheless, the findings in humans 
seem to reproduce those that have been reported regarding the OT system in animal models 
of ASD (genetic, pharmacological or environmental), insofar as studies using different models 
have diverged between increases, decreases or absence of alterations in OT or its receptor 
expression in several regions of the rodent brain (such as the amygdala, hippocampus, lateral 
septum or the cortex)(98). For an extensive exploration of these studies, readers are referred 
to a recent review on this preclinical evidence(98). 
OT is typically synthesized as a prohormone that is sequentially processed to peptides 
in a chain of enzymatic hydrolysis reactions, whose final step is catalysed by the 
peptidylglycine alpha-amidating monooxygenase (PAM)(99). These peptides are the bioactive 
amidated form (OT) and the C-terminal extended peptides, OT-Gly, OT-Gly-Lys and OT-Gly-
Lys-Arg, collectively designated as OT-X(99). Interestingly, one study reporting decreased 
levels of OT in ASD patients extended its approach to quantify OT’s C-terminal peptides and 
found them to be increased(100). Specifically, OT-X/OT was found to be elevated significantly 
in ASD patients. This study suggests that disruption of OT’s peptide processing may be 
involved in its dysregulation during ASD. To date, alterations in PAM expression and/or activity 
during ASD remain to be described. Moreover, no study to date has inspected the contribution 
of PAM genetic variability to ASD liability. Further studies pursuing these questions may help to 
more fully characterize the role of peptide processing disruption in ASD and bring new insights 
on the molecular mechanisms underlying these disorders. 
Regarding AVP, 4 studies failed to find significant associations between its levels and 
ASD diagnosis, with only 1 study reporting lower plasmatic and salivary AVP levels in ASD. 
Although limited by methodological constraints related to peptide measurements, a joint 
analysis of the available data suggests this picture may be more complex than previously 
thought, due to the fact that ASD represents a heterogeneous group of disorders, which makes 
diagnosis and treatment a substantial challenge(101). We suggest that inconsistencies in the 
ASD nonapeptides literature may reflect some of this diagnostic heterogeneity and that further 
studies evaluating the extent to which nonapeptide dysregulation may represent an 
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endophenotype associated with specific ASD subtypes will be particularly useful. These 
studies should be very valuable in this early-phase of clinical trials of OT augmentation therapy 
in ASD, because it is possible that only a subset of ASD patients with OT’s deficits may really 
benefit from this intervention(102). We note that in one of the studies reporting higher OT 
plasma levels in ASD cases, alterations in the OT signalling cascade could be observed as 
well. It remains unclear whether this elevation in OT levels is truly associated with an effective 
increase in OT tonus or to some other step in the signalling cascade. It is possible also that 
elevations of OT levels may correspond to a compensatory response to alterations in receptor 
signalling observed in some ASD patients, namely its repression. In fact, several DNA 
methylation sites (CpG dinucleotides) of the OT receptor gene show significant increases in 
their degree of methylation in peripheral blood cells and temporal cortex samples of ASD 
patients, when compared to controls(103). Evidence supporting similar alterations for OT, AVP 
or AVP receptors is not yet available. Further studies combining concomitant assessments of 
nonapeptides’ baseline and evoked responses, as well as epigenetic analysis of the genes 
involved in their signalling cascade in the same experimental setup may help to address this 
question and provide a more complete picture regarding nonapeptides signalling for individuals 
with ASD. Importantly, even in the studies where no appreciable differences in OT levels were 
observed between ASD and control groups, OT and AVP levels were found to correlate with 
autistic symptomology. Moreover, several measures of social function, such as theory of mind 
or social communication were significantly correlated for both ASD and healthy participants 
(although these associations were not replicated in all studies). We speculate that even if 
peripheral OT/AVP levels do not have diagnostic or physiopathological relevance, they may 
represent clinically useful prognostic biomarkers of social functioning in ASD patients.  
We also stress that although some evidence suggests OT baseline levels are lower in 
ASD patients, their OT system seems to respond to social interaction similarly to control 
subjects(104), which argues against the possibility of the complete loss of OT responsiveness 
in ASD. Evidence supporting this conclusion is scarce and replications are needed, 
nevertheless it opens interesting windows of opportunity for therapeutic strategies. For 
instance, once sustained, social-based psychotherapy training may retune the OT system to 
normal baseline functioning without the need for a chronic drug therapy. Further studies and 
clinical trials exploring this possibility seem timely and warranted. From the studies reviewed 
here, only one apparent exception emerged: OT secretion in response to a hydrocortisone (a 
typical stress hormone) was not observed for the ASD sample, although present in  
controls(105). Although this is a single study and it requires replication, it suggests the 
possibility that specific impairments in stress-mediated OT release may be present in ASD.  
Evidence suggesting that, even if production and secretion of OT is not altered in at 
least some ASD patients, significant impairment of signalling can occur, came from a single 
study reporting that, while in controls salivary OT correlated with visual attention to social 
stimuli, this correlation was not observed in ASD patients (even when OT levels were similar 
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between groups) (59). This hypothesis is further supported by the observation that OT receptor 
expression may be decreased in the brain of ASD patients(106). 
Another point deserving mention refers to the putative sexual dimorphism present in 
the nonapeptide involvement in ASD. Indeed, one study reported that OT deficits may be 
specific of ASD males, although another study comparing both sexes has failed to find 
differences. The latter study also reported that while higher OT levels were associated with 
higher anxiety in ASD girls, the same association was not found in ASD boys. Moreover, AVP, 
which was positively associated with restricted and repetitive behaviours in girls with ASD, was 
negatively (but non-significantly) associated with these behaviours in boys with ASD(107). We 
speculate that, similarly to that observed for healthy adults, OTergic modulation of socio-
emotional behaviour in youth with ASD may present sexual dimorphism and, thus, findings 
obtained from male samples should not be presumed to be extrapolatable for females. Both-
sex studies are necessary in order to fully clarify the role of OT in ASD physiopathology and its 
potential as a drug therapy, even acknowledging the higher prevalence of ASD in males(108). 
Alterations in the age-changes of OT secretion were reported in ASD as well, raising new 
hypothesis about a possible OT system maturation disruption in this disorder(109). 
 
4.6.2 Others (ADHD, OCD, Depression, Anxiety, Conduct problems and Prader-
Willi syndrome) 
 
 Expanding the focus from ASD to other clinical samples, 8 studies were conducted to 
examine the association between CSF, plasma or salivary OT/AVP concentrations and ADHD, 
OCD, Depression, Anxiety, Conduct problems or Prader-Willi syndrome’s diagnosis and 
symptom-related dimensions. Remarkable findings include: 1) an association between AVP 
and OT and symptomatic dimensions for individuals diagnosed with OCD, including 
concomitant depressive and anxiety symptoms(110); 2) a decrease in OT levels in ADHD 
patients and its association with symptom-related dimensions, such as impulsivity, and general 
social cognition, including empathic abilities(111, 112); 3) an exacerbation of OT responses to 
child-mother interactions for children diagnosed with separation anxiety disorder(113); 4) 
elevations of OT during adolescent treatment-resistant depression, although no significant 
association with depressive symptoms were identified(114); 5) a negative association between 
salivary OT and callous-unemotional traits for cases diagnosed with  conduct disorder(115); 6) 
an elevation of plasma levels of OT for PWS cases(116), although in apparent contradiction 
with recent studies where positive effects of OT augmentation on anxiety, social function and 
appetite drive were reported for PWS children(117).  
While significant associations between levels of hypothalamic nonapeptides and 
domains of pathological social cognition, such as social anxiety or callous-unemotional traits, 
are consistent with prior research findings, their association with domains such as impulsivity 
or obsessive-compulsive phenomena are surprising and may reflect roles of these 
neuropeptides not previously considered by researchers. Indeed, impulsivity and obsessive-
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compulsive symptoms have been associated mainly with imbalances of dopamine and 
serotonin(118, 119). However, we note that several interactions between the OT and the 
dopamine or the serotonin systems have been demonstrated in preclinical studies using animal 
models and are likely to exist in the human brain as well(120, 121). We cannot, thus, exclude 
the possibility that effects of OT/AVP on other neurochemical systems might mediate the 
proposed actions of these neuropeptides on cognitive processes not involving direct social 
processing. The links between OT and feeding behaviour constitutes an emergent field of 
research that receives support from preclinical studies using animal models that suggest OT 
may present anorexinogenic properties - limiting the intake of palatable food(122, 123). These 
findings are not easily reconciled with the apparent increase of OT observed in PWS patients, 
where hyperphagia has been a pivotal clinical marker of the disease(124) . However, previous 
studies reported a decrease in OTR gene expression and density in the hypothalamic 
paraventricular nucleus of PWS males. It may be that this increase in the release of OT to the 
periphery may thus represent a feedback response to decreased OTR signalling attempting to 
maintain tonic signalling in homeostatic levels. 
Overall, one should note the evidence obtained for neuropsychiatric clinical 
populations does not permit drawing definitive conclusions about the extent to which 
observations of altered levels of these peptides in biological fluids may be directly implicated in 
the genesis of aberrant behaviour or if they might represent a general defensive signal of the 
body to disease. Indeed, the observation of several deficits relevant to human 
neurodevelopmental disorders in OT genes using animal knockouts support the hypothesis of 
links between the OT-system and the pathogenesis of social deficits(125, 126), characteristic 
of disorders such as ASD. However, cumulative evidence over the last years has been 
supporting the notion that OT may be an important higher regulator of the immune function, 
both in the CNS (through microglia activity regulation(127)) and in the body’s periphery 
(promoting thymus and bone marrow development, that strengthens immune defence and 
maintains immune homeostasis)(128, 129). Thus, we should not exclude that general 
physiological responses of the OT system to disease may cause variations of its levels in 
bodily fluids that may not necessarily be related to socio-affective impairment (but instead 
reflect other aspects of OT’s physiology). 
 
5. CONCLUSION 
 
An increasing number of studies exploring the association between endogenous 
OT/AVP and socio-emotional behaviour or its disruption during neuropsychiatric 
/neurodevelopmental disorder in youth have been conducted over the last 24 years. Studies 
are limited by their correlational designs, constraints relating to the reliability of the 
methodologies currently used for quantifying nonapeptides in biological fluids, and 
uncertainties relating to the validity of peripheral measurements as proxies of central OT 
release. Each of these issues limit the possibility of drawing definitive conclusions based on 
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the evidence presented. Despite this, the accumulating evidence is generally suggestive of a 
of nonapeptide(s) involvement in socio-emotional functioning and its disruption during disease. 
Similarly to findings observed for adults, disparities relating to unreplicated or opposite findings 
in independent studies have been observed in paediatric populations. Moreover, context-
dependent and sexually dimorphic effects have been reported as well (see BOX1). These 
studies have also provided preliminary hints concerning peculiarities of the hypothalamic 
nonapeptide(s) physiology during the different age stages (which may be particularly 
informative since in post-natal developmental periods prior to complete sexual maturation, 
adult studies may indeed be less representative). Although the core findings tend to converge 
with evidence coming from adults, they also suggest that important differences between age 
stages may exist: for instance, while in adult males, OT has been associated with trust and 
generosity to in-group members(130), the only study conducted to date with a similar design in 
a paediatric sample found the opposite association(67). Interestingly, opposite findings to 
those observed in adult samples have been reported in young and adolescent animal studies 
with direct OT pharmacological manipulation as well – for instance, an impairment in the 
classical pair-bonding observed in male voles when treated with low-dose OT between 
weaning and sexual maturity(27). While preliminary, these findings support the idea that 
dynamic changes in the modulation of social and affective processing during development by 
hypothalamic nonapeptides may exist, which challenges the generalizability of findings from 
adult samples. However, considering the absence of neurophysiological measures in the vast 
majority of the studies we included here, this review is limited in the insights it may provide 
regarding the neurobiological circuits underpinning the contribution of nonapeptides to 
behaviour at these ages. 
Paediatric neurodevelopmental disorders constitute one of the most promising 
translational applications of intranasal OT. This field will benefit from standardizing the 
methods used for measurement and reporting on hypothalamic nonapeptides to facilitate 
quantitative synthesis. Additionally, the field would benefit from a careful examination of the 
extent to which OT measurements in peripheral fluids may serve as surrogates for OT brain 
physiology. From that point of view, the advent of studies exploring and validating mass-
spectrometry quantification of neuropeptides in biological fluids, a non-biased approach not 
depending on antibody specificity, will be particularly useful. Also, even though there are 
ethical and logistic constraints, ideally, future studies using both animal and human participants 
in paediatric ages should increase their reliance on controlled and standardized direct 
manipulations of nonapeptide levels in pharmacological designs, overcoming some of the 
criticisms surrounding OT/AVP probing in peripheral fluids.  
Several questions concerning the role of nonaneptides in social cognition and affective 
processing in paediatric neurodevelopmental/neuropsychiatric health and pathology remain to 
be explored (we propose some in BOX2). As methodological and ethical constraints are dealt 
with, inquisitive neuroscientists, children and adolescent psychiatric care providers and, 
specially, young patients will stand to gain.  
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BOX1: Highlighted suggestions from current evidence 
 
   
1) OT is putatively implicated in infant-parental attachment and reciprocal 
behaviour; 
2) OT is putatively implicated in prosocial behaviour and social engagement with 
both peers and parents during childhood;  
3) There is suggestive cross-generation transmission of OT physiological pathways;  
4) OT is putatively implicated in parental, more than peer, support for social buffering 
of stress responses (highlighting the importance of physical cues – touch or vocal), during 
childhood and adolescence;  
5) OT is putatively involved in the regulation of visual attention to social relevant 
cues, such as the eye’s region of a human face;  
6) Early life adversity putatively affects youth’s nonapeptidergic responses (basal and 
evoked), although the direction and the adaptive vs pathological value of these effects remain 
to clarify;  
7) OT and AVP secretion and/or processing is putatively impaired in ASD; 
8) ASD patients, in which lower levels of OT were observed, seem to conserve 
functional OT secretion systems during social interaction;  
9) Non-invasive measurements of nonapeptides in peripheral biological fluids 
may index some aspects of social cognition, such as theory of mind or social 
communication, even in patients where dysregulation of these peptides was not observed;  
10) Dysregulation of both OT and AVP systems may exist in a bundle of 
disorders other than ASD, involving primarily social symptoms but also other 
psychopathological dimensions such as impulsivity or obsessive-compulsive symptoms. 
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BOX 2: Questions for future research 
1. What are the biological mechanisms involved in OT’s and AVP’s regulation of socio-
emotional behaviour early in human life? What brain areas or neurochemical 
systems are involved in their modulatory role?  
2. Are there significant differences between adult and paediatric populations 
regarding the modulatory role of hypothalamic nonapeptides in socio-emotional 
processing? What aspects are different? Can the results from adults be directly 
extrapolated to children and adolescents? 
3. Are there significant sex differences between males and females in respect to 
OT/AVP modulation of socio-emotional behaviour, even in pre-puberty developmental 
stages? Which differences are these? Can the results from male studies be directly 
extrapolated to females during these phases of human development? 
4. What are the biological mechanisms involved in cross-generation transmission of 
OT pathways? Are they presenting in AVP’s physiology as well? 
5. Can animal models be reliably used to foster research on the roles of hypothalamic 
nonapeptides in socio-emotional processing during development? Which species may 
more adequately model human socioemotional ontogenesis? 
6. Can attachment relationships be in part modifiable, not only through psycho-
education and implementation of behavioural strategies, but also through 
implementation of nonapeptides-based pharmacotherapies for high-risk 
populations? 
7. What are the biological mechanisms underlying disruption of OT and AVP signalling 
after early-life adversity? Do they involve epigenetic reprogramming of 
nonapeptides-related genes? Are they stress-related? Can the socio-emotional 
deficits of these subjects be remediated through implementation of nonapeptides-
based augmentation pharmacotherapies? 
8. May social-based interventions retune the OT system during ASD and persistently 
remediate the hypo-oxytocinemia reported in some patients?  
9. Can measurements of nonapeptides in peripheral biological fluids represent 
clinically relevant biomarkers for paediatric neurodevelopmental and 
neuropsychiatric disorders (diagnosis, prognosis or treatment response)? 
10. Can disparity in plasma and serum OT concentrations represent ASD-related 
endophenotypes associated with different biological sub-types of this heterogeneous 
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disorder? May they reflect differences in the underlying pathophysiological 
mechanisms? 
11. Can OT or AVP-based augmentation therapies be useful in the treatment of asocial 
symptoms during paediatric neurodevelopmental and neuropsychiatric disorders? Can 
its application go beyond social dimensions? 
12. Is chronic OT or AVP-based augmentation therapies safe during early phases of 
human psycho-socio-emotional development? Can them entice modifications (positive 
or negative) persisting into the adult life? 
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Figures 
 
Fig. 1 – Evolution of research interest on hypothalamic peptides oxytocin and 
vasopressin in adults’ and youths’ sociability (PUBMED-indexed publications until the end 
of 2016); source: https://www.ncbi.nlm.nih.gov/pubmed/; queries: “(oxytocin OR vasopressin 
OR arginine vasopressin) AND (children OR infants OR adolescents) AND social” vs “(oxytocin 
OR vasopressin OR arginine vasopressin) AND adults AND social”; Accompanying the 
increasing flood of studies addressing the role of OT/AVP on human social behaviour, an 
increase in the absolute number of  PUBMED-indexed publications exploring the role of these 
peptides in socio-affective behaviour in paediatric populations could be observed as well – this 
increase alludes to the crescent interest of the research community on these topics over the 
last decades; 
 
Fig. 2 – Process of selection of studies for systematic review according to PRISMA 
guidelines (628 records published up to March 2017 were identified via MEDLINE searching; 
1 additional record was identified during the time of the revision of this manuscript and was 
considered; Duplicates were automatically identified and removed; Titles, asbtracts and key-
words were screened to identify potential full-text articles fitting our inclusion and exclusion 
criteria; 584 records were identified as irrelevant and the remaining 45 assessed for full-text 
eligibility; no full-text was discarded during this phase, thus all the 45 full-texts were included 
for qualitative synthesis;)   
 
Fig. 3 – Overview of the characteristics of the reviewed studies (The methodology and the 
target population of the identified studies varied considerably: The studies’ populations 
included neonates and babies (up to 6 months), children (6 months – 5 years old), pre-
adolescents (7-12 years old) and adolescents (12-18 years old) but also participant’s parents 
or other caregivers; while some studies focused on the application of validated psychological 
instruments destined to evaluate socioemotional behaviour or psychopathology, others 
focused on controlled lab-based paradigms or ecological evaluation of child-parents’ 
interactions; heterogeneity could be identified in the methodological approaches used, namely 
in the time interval spanned by the measurement, in the type of biological fluids chosen for 
analysing neuropeptides’ levels, in the method used for sample collection and in the assay 
techniques used for neuropeptide measurements) 
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Tables 
Table 1. A 12-criteria score list to appraise the quality of the studies reviewed and the 
percentage of studies complying with the highest (from 0 to 3) within each criterion. 
 
 
Quality Assessment Criteria % of compliance 
1. Were the hypothesis and objectives of the study clearly 
described? 
69% 
2. Have the authors used methods that can test their 
hypothesis? Was a valid cognitive task assigned to elicit the 
desired effects in the participants? 
88% 
3. Were the study’s inclusion criteria for the participants clearly 
described (e.g. ethnicity, age range, gender, neuropsychiatric 
and other medical conditions and handedness)? 
43% 
4. Were there sufficient attempts to account for demographic 
and neuropsychological variability amongst participants [e.g 
age, gender, handedness, IQ, level of education]? 
38% 
5. Were the behavioural/psychological assessments clearly 
described and the tools used validated? 
83% 
6. Are aspects related to fluid sampling and neuropeptides 
measurement clearly described? 
45% 
7. Did the authors discuss their measurements in face of the 
ranges of the method’s sensitivity? 
40% 
8. Are missing values or outliers exclusion identified and/or  
justified? 
38% 
9. Did the study include an a priori calculation of power to 
define sample sizes? Did this calculation took into account the 
reliability of the measures used? 
45% 
10. Is the statistical methodology clearly explained? 71% 
11. Were effect sizes reported for significant results (e.g. 
Cohen’s d, Pearson’s correlation, odds ratio or risk ratios)? 
47% 
12. Was a consensual statistical significance threshold set (i.e. 
p< 0.05 after correction for multiple comparisons)? 
95% 
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Study Aims Sample Method of OT/AVP 
measurement 
Biological sample 
collection 
Social measures and/or 
stimulus 
Main findings 
White-Traut 
et al. (1998) 
To determine 
whether massage 
in the newborn 
would increase 
urine OT levels; 
36 newborn infants born 
via cesarean section   
Urinary OT 
detected by 
RIA 
NA Amount of crying during the 
massage procedure  
OT levels significantly  in infants who 
cried (surrogate of stress); 
 
Clark et al. 
(2013) 
To understand the 
role of OT biology 
in sociability, at 
term, at 3 months, 
and at 6 months of 
age; 
18 human neonates (27 – 
40 weeks of gestation, 
10 vaginal delivery and 
8 C-section) (12M, 6F) & 
their parents 
CSF OT levels 
measured by 
ELISA 
Lumbar puncture 
within 72h of birth 
At term: Parental list of 
soothing techniques that 
helped to calm their baby 
At 3 months: Parent Infant 
Behavior Questionnaire 
At 6 months: Parent Infant 
Behavior Questionnaire and 
Relating to Others subscale 
from the Socialization section 
of the Vineland Adaptive 
Behavior Scales 
At term:  OT levels were associated 
with needing feeding to be soothed;  
At 3 months:  neonatal OT levels 
were significantly associated with  
crying when parents were not 
immediately responsive;  
At 6 months:  levels of OT were 
associated with: a  crying for contact 
and positively related to the Relating to 
Others subscale of the Vineland 
instrument;   
Feldman et 
al. (2010) 
 
 
 
 
 
To examine the 
cross-generation 
transmission of 
OT in humans; 
55 infants (4-6 months, 50 
with vaginal delivery) and 
55 parents (36 mothers 
and 19 fathers, not 
couples)  
 
 
 
 
Salivary OT, 
measured by 
ELISA 
1-4 PM 
 
Babies: 1h following 
the last breastfeeding 
and 1h prior to the 
next one 
 
Baseline samples 
collected after 10 
minutes without touch 
between parents and 
the baby 
 
Post-interaction 
samples collected 15 
15-min “play-and-touch” 
interaction, between parents 
and their infants, that would 
include any type of touch they 
typically use 
No differences between the OT levels 
of male and female infants or between 
infants interacting with mother or 
father at the two assessments; 
Both parental and child display the OT 
response and  their OT levels after 
an episode of joint play; 
Parent and infant's OT concentrations 
showed significant correlations at both 
the pre- and post-interaction 
assessments; 
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Table 2. 
Overview of the studies with infants (Abbreviations: ELISA – Enzyme Linked Immunosorbent Assay; RIA – Radioimmunoassay; OT – oxytocin; AVP - vasopressin) 
 
 
 
  
minutes after 
interaction 
Weisman et 
al (2012) 
To study whether 
intranasal OT 
intervention to the 
parent can have 
parallel effects on 
the infant;  
35 fathers and their 5-
month-old infants 
(17M,18F) 
Salivary OT 
determined by 
ELISA assay 
1 – 5 PM 
Parents asked to 
abstain from alcohol 
or caffeine in the 
day and avoid food 
intake 2h before 
arrival 
Baseline samples for 
the father collected 
in a isolated context 
without interaction 
with the child 
Face-to-face still-face 
paradigm 
Free-play episode coded with 
measures of the Parent-infant 
synchrony construct 
Infants whose fathers received OT 
showed an  in salivary OT between 
the first (before father-infant 
interaction) and second assessments; 
Child OT response correlated with 
father’s touch,  latencies to father 
gaze aversion,  child object 
manipulation and father-child touch 
synchrony 
Weber et al 
(2017) 
To examine 
associations 
among infant 
plasma OT 
trajectories and 
maternal-infant 
social 
engagement 
behaviours during 
initial 
hospitalization of 
premature infants 
28 extremely premature 
infants (average age at 
birth 27,25 weeks) (14M, 
14F) 
Plasma OT 
measured by 
ELISA 
(unextracted 
samples) 
11 PM – 2 AM 
Sample collection 
started at day 14 of 
life and performed 
weekly until baby 
achieve 34 weeks of 
post-menstrual age; 
collection was 
performed before 
feeding 
Parent-Child Early Relational 
Assessment 
Negative association between infant 
plasma OT levels and infant social 
engagement behaviors 
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Table 3) Studies with Preschool and 
school Children 
 
 
 
  
Study Aims Sample Method of OT/AVP 
measurement 
Biological 
sample 
collection 
Social measures and/or 
stimulus 
Main findings 
Feldman 
et al 
(2013) 
To investigate the 
cross-generation 
transfer of OT 
50 3-years children 
50 child “best-friends” 
Salivary OT 
Measured by  
ELISA 
 
4 – 8 PM 
(home) 
Time between 
feeding, not 
including the 
30 mins 
immediately 
after or before 
feeding 
 
Method: 
Salivettes 
7-min parent-child interaction 
using age-appropriate toys + 
10-min interaction between 
the child and best friend 
during structured play – 
determination of Social 
Reciprocity composite after 
behavior coding through the 
Coding Interactive Behavior 
Manual 
Child OT correlated with Maternal and 
Paternal OT 
Child OT correlated with  Social 
Reciprocity with best-friend 
Maternal CD38 rs3796863 A allele and 
the interaction of CD38 rs3796863xEarly 
Maternal Care predicted children OT 
levels: among children receiving  
maternal care, those with mothers 
homozygous for the high-risk CC allele 
had  OT levels than those whose 
mothers were A-carriers. 
Fujii et al 
(2016) 
To examine the 
association 
between salivary 
OT and 
generosity in 
Preschoolers 
50 (24M, 26F) 
(average age 4-5 years) 
Salivary OT 
measured by 
ELISA after 
extraction 
9 – 11 AM 
 
Method: 
Passive-droll 
method 
Dictator’s game Boys: OT levels were negatively 
associated with allocations made to both 
ingroup and outgroup members; 
Girls: OT levels were positively related to 
allocations made to ingroup members, 
and unrelated to allocations made to 
outgroup members; 
Nishizato 
et al. 
(2017) 
To examine the 
developmental 
relationship 
between salivary 
OT and social 
attention during 
149 children (76M, 73F) 
(age range 5-90 months) 
Salivary OT 
measured by 
ELISA 
Method: 
Salivettes 
Eye-tracking during visual 
exploration of pictures 
depicting faces, people and 
objects 
Negative association of salivary OT with 
age; 
No significant sex difference was 
observed with regard to salivary OT 
levels; 
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Table 3. Overview of studies with prescho 
ol and school children (Abbreviations: ELISA – Enzyme Linked Immunosorbent Assay; RIA – Radioimmunoassay; CSF – cerebrospinal fluid; OT – oxytocin; AVP - vasopressin) 
 
 
  
the young 
childhood 
Positive correlations were observed 
between OT and the fixation time spent 
on the eye area of the face; negative 
correlations were observed between OT 
and the fixation time spent on the mouth 
area; 
OT mediates the relationship between 
age and visual attention to the eye area 
(Human face); 
Salivary OT levels in young children are 
modulated by the OXTR rs53576 
polymorphism (AA<G-carriers); 
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 Table 4) Studies with Pre-adolescents and Adolescents 
 
  
Study Aims Sample Method of 
OT/AVP 
measurement 
Biological sample 
collection 
Social measures  
and/or stimulus 
Main findings 
Seltzer et 
al. (2010) 
To study if 
OT’s 
release is 
contingent 
to contact 
with the 
mother 
after stress 
 61 girls and 
their 
mothers  
(age range 7-
12 years) 
 
Urinary OT 
analyzed by 
ELISA 
Session began at 4 
PM 
Urine samples 
collected at arrival, 
baseline (after 30 
mins of 
acclimatization), 30 
and 60 minutes 
post-stressor 
1)Trier Social Stress Test for 
Children 
2) Period of 15-min of contact with 
their mothers (either direct contact 
or verbal), versus the control group 
that had no contact. 
 in OT following comforting by their mothers involving direct 
physical contact, and in response to speech with their mothers 
even in the absence of all other types of somatosensory 
contact;  
OT levels did not change for children who rested alone and 
received no form of maternal comforting following the stressor; 
Seltzer et 
al. (2012) 
To examine 
the OT and 
cortisol 
responses of 
female 
children after 
undergoing a 
stressor 
68 girls and 
their 
mothers 
(age range 7-
12 years) 
 
 
Urinary OT   
analyzed by 
ELISA 
Session began at 4 
PM 
Urine samples 
collected at 
arrival, 
baseline (after 
30 mins of 
acclimatization)
, 30 and 60 
minutes post-
stressor 
Trier Social Stress Test for Children 
After stressor: 17 in the “no 
contact” condition, as a negative 
control; 17 in the “full contact” 
condition, as a positive control; 17 in 
the “verbal contact” condition; 
17 in the “instant message” 
condition; 
Children using instant messages to communicate maintained 
levels of OT that did not differ from OT measures in the 
negative control group 
 levels of OT in children permitted to make either direct 
contact or contact over the phone; these groups did not differ 
from one another but they did differ from both the instant 
message and negative control conditions  
Carson et 
al (2014) 
To test (1) 
whether 
plasma OT 
predict CSF 
OT and (2) 
test whether 
OT predicts 
anxiety; 
27 pediatric 
and adult 
patients 
(average age 
of 16 years) 
(11M, 16F) 
Subset (N=10) 
of child 
CSF and plasma 
OXT 
concentration 
were quantified 
by ELISA 
(extracted 
samples) 
Within 72h of birth Parent version of the Spence 
Children’s Anxiety Scale. 
CSF OT was significantly  than plasma OT; 
Plasma OT significantly and positively predicted CSF OT in all 
subjects; the same was observed when only children (⩽ 18 
years) were included in the analysis;   
Both plasma and CSF OT negatively predicted anxiety scores 
in children; 
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Table 4. Overview of studies with pre- and adolescents (Abbreviations: ELISA – Enzyme Linked Immunosorbent Assay; RIA – Radioimmunoassay; CSF – cerebrospinal fluid; OT 
– oxytocin; AVP - vasopressin) 
 
 
  
participants 
aged 6–18 
years old 
Doom et 
al. (2016) 
To examine 
the effect of 
social support 
on oxytocin’s 
response to 
stress 
54 children 
(28M, 26F), 
9-10 years 
55 
adolescents 
(25M, 30F), 
15-16 years 
Urinary OT 
measured by 
ELISA 
2:30 – 4:30 PM 
 
Urine collected 25 
mins after arrival 
and within 10 mins 
after last saliva 
sample for cortisol 
measurements 
Social Trier Stress test (subjects 
prepared for the test with a friend or 
with a parent) 
Adolescents present  levels of urinary OT than children; 
Males present   levels of urinary OT than females; 
Urinary oxytocin  across the task when the male participants 
prepared with a friend but not with a parent - this effect was 
independent of age; no significant  was observed for 
females; 
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Table 5)  Studies with children after adverse early-life environment 
 
   
Study Aims Sample Method of OT/AVP 
measurement 
Biological sample 
collection 
Social measures and/or 
stimulus 
Main findings 
Wiesmer -
Fries et al. 
(2005) 
To assess 
baseline 
OT/AVP and 
their 
responses to 
social and 
physical 
interactions  
18 adopted children 
who had resided in 
orphanages (6M, 
12F) (average age 
4,47 years) 
21 children reared 
by their biological 
parents with age 
matched and similar 
high socioeconomic 
backgrounds (9M, 
12F) (average age 
4,51 years) 
Urinary OT and AVP 
analyzed by 
ELISA (after HPLC 
separation) 
 
Basal levels determined by 
averaging 12h overninght 
urine collections from 4 
separate mornings 
 
Post-interaction samples 
collected 15 mins after task 
30-min interactions between 
children and their mothers, 
and between children and an 
unfamiliar female 
experimenter, with regularly 
timed physical contact 
OT and AVP were equivalent for boys and girls, in both 
groups 
Basal levels of OT did not differ between the adopted 
and control children;  
Adopted children present  baseline levels of AVP than 
controls;  
OT levels for biological family-reared children  after 
physical contact with their mothers but adopted children 
did not show this response; 
AVP levels does not vary as a function of contact neither 
in the mother nor in the stranger condition in any of the 
groups; 
Seltzer et al. 
(2014) 
 
To test if (1) 
physical 
abuse is 
associated 
with OT 
response to a 
social stressor 
and (2) 
whether OT 
and cortisol 
levels are 
associated 
after a 
stressor; 
37 “maltreated 
children” who had 
experienced verified 
physical abuse 
(17M, 21F) 
36 “typically 
developing” children 
with similar 
sociodemographic 
characteristics 
(18M, 18F) 
(age range 8 – 11.5 
years) 
Urinary OT levels 
analyzed by ELISA 
Arrival at 4 PM 
 
Baseline urine collected after 
30 mins of acclimatization 
 
Post-stressor collected 60 
mins after stress challenge 
Trier Social Stress Test for 
children to induce a stress 
response 
Girls with histories of physical abuse have  levels of 
urinary OT and  levels of salivary cortisol following a 
stressor when compared to controls; Abused and control 
boys do not differ in their hormonal responses;  
Children’s salivary CT responses post-stressor were 
negatively correlated with urinary OT responses  
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Mizushima et 
al. (2015) 
To investigate 
differences in 
secretion 
patterns of 
cortisol (CT) 
and oxytocin 
(OT) among 
children who 
experienced 
children 
maltreatment; 
38 maltreated 
children (18M, 18F):  
23 categorized as 
“Settled” (average 
age 12.2 years) 
15 as “Unsettled” 
(average age 13.1 
years) 
26 age- and gender-
matched typically 
developing (TD) 
children (12M, 14F) 
(average age 12,6 
years) 
Salivary OT 
determined by 
ELISA  
Awakening (within 1h) and 
bedtime samples 
Method: Salivettes 
ADHD symptoms: Japanese 
version of the ADHD Rating 
Scale-IV  
ASD symptoms: Autism-
Spectrum Quotient-children’s 
version (AQ) 
Strengths and Difficulties 
Questionnaire (SDQ) 
Depression Self-Rating Scale 
for Children (DSRS-C: 
Japanese version) 
Traumatic experiences: UCLA 
PTSD Index for DSM-IV 
(UPID) the Impact of Event 
Scale Revised (IES-R) and the 
trauma symptom checklist for 
children (TSCC) 
 
Children in “Settled” environments have a marked  in 
the bedtime salivary OT level compared with TD 
children; 
 
 
Apter-Levy et 
al. (2013) 
To investigate 
the role of 
maternal 
depression in 
children’s 
salivary OT 
levels 
149 6-years children 
(46 from 
depressed 
mothers, 103 from 
never-depressed 
mothers as 
comparison 
subjects) (51% M, 
49%F) 
 
Salivary OT levels 
determined by 
ELISA 
 
Method: Salivettes 
 
Sampling in duplicate and the 
measures averaged 
Development and Well-Being 
Assessment 
10-min of mother-child 
interactions with preselected 
toys coded with the Coding 
Interactive Behavior manual 
 salivary OT levels in the mothers, fathers and children 
in families with depressed mothers and father’s 
emotional distress when compared with controls AC
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Table 5. Overview of studies with children after early-life adverse environment (Abbreviations: ELISA – Enzyme Linked Immunosorbent Assay; HPLC – High Pressure 
Liquid Chromatography; ADHD – Attention Deficit and Hyperactivity Disorder; ASD – Autism Spectrum Disorder; OT – oxytocin; AVP - vasopressin) 
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Table 6. Overview of studies with clinical samples: 6.1) ASD; 6.2) Others (Abbreviations: ELISA – Enzyme Linked Immunosorbent Assay; RIA – Radioimmunoassay; CSF – cerebrospinal fluid; ADHD – Attention Deficit and Hyperactivity Disorder; ASD – Autism Spectrum 
Disorder; OT – oxytocin; AVP – vasopressin; PWS – Prader-Willi syndrome) 
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Table 6.1) Clinical samples  (ASD)     
Study Aims Sample Method of 
OT/AVP 
measurement 
Biological sample 
collection 
Social measures and/or stimulus Main findings 
Modahl et 
al. (1998) 
 
To determine 
abnormalities 
in OT of 
autistic 
children 
29 autistic boys  
30 non-autistic 
boys used as a 
control  
(age 5-12 years) 
Plasma OT 
levels measured 
by RIA 
(extracted 
samples) 
 
Within 2h of noon 
 
2h fasting 
Children measures: 
Peabody Picture Vocabulary Test 
(PPVT-R) 
Parent Interviews: 
The Vineland Adaptive Behavior 
Scales (VABS) 
 
Autistic children presented  OT levels than controls; 
OT  with age in the controls but not the autistic children; 
Elevated OT was associated with  scores on social and 
developmental measures for the normal children;  
For the autistic group, OT was negatively associated with 
Daily Living Skills, Personal Care, and Community Skills 
(these relationships were strongest in a subset of autistic 
children identified as aloof) 
  
Green et al. 
(2001) 
To determine 
whether there 
are changes in 
OT peptide 
forms in 
autistic 
children 
28 boys 
diagnosed with 
DSM-IV autistic 
disorder 
31 age-matched 
and 
nonpsychiatric 
boys  
(age range 6-11 
years) 
Plasma OT 
levels measured 
with peptide RIA 
(extracted 
samples) 
Within 2h of noon 
 
2h fasting 
1) Brief questionnaire regarding 
variables that could affect the 
measurement of peptide levels; 
2) Vineland Adaptive Behavior 
Scales 
3) Stanford Binet fourth edition  
4) Copying and Pattern Analysis 
subtests  
5) Peabody Picture Vocabulary Test 
(PPVT) 
6) Autistic Disorders Checklist and 
an adaptation based on DSM-IV 
criteria 
 in plasma OT, an  in OT-X and an  in the ratio of OT-
X/OT in the autistic sample. 
OT-X  with age only in the autistic group 
OT-X was not significantly correlated with any of the Vineland 
domains or intellectual scores in either group. 
Al-Ayadhi 
(2005) 
To assess 
plasma levels 
of OT and AVP 
in autistic 
children 
65 children 
diagnosed with 
DSM-IV autistic 
disorder (61M, 4F) 
77 healthy age 
and sex matched 
controls (71M, 6F) 
(age range 3,5 – 
14 years) 
 
Plasma OT and 
AVP levels 
measured by 
ELISA 
(unextracted 
samples)  
NA Diagnosis of autistic disorders OT and AVP were significantly  in the autistic group, as 
compared to the control group 
No association between age or autism degree and the 
oxytocin or vasopressin levels in both groups 
Corbett et 
al. (2011) 
To evaluate 
the impact of 
an intervention 
to improve 
socioemotiona
l functioning in 
autistic 
children 
8 children with 
autism spectrum 
disorder (7M, 1F)  
8 children, used as 
peers with typical 
development (4M, 
4F) 
(age range: 6-17 
years)  
Plasma OT 
levels 
determined by 
ELISA  
NA Social Emotional NeuroScience 
Endocrinology (SENSE) Theatre 
(designed to improve 
socioemotional functioning and 
reduce stress in autistic children) 
No significant impact of intervention on OT levels neither in 
ASD nor in controls 
Zhang et al. 
(2012) 
To assess the 
efficacy of 
Transcutaneo
us electrical 
acupoint 
simulation 
(TEAS) 
76 autistic 
children:  
37 receiving TEAS 
(34M, 3F) 
39 control group 
(34M,5F) 
(around 4 years) 
Plasma OT 
/AVP levels 
determined by 
ELISA 
(unextracted 
samples) 
 
9-11 AM 
 
Parents present during 
sampling 
Childhood Autism Rating Scale 
(CARS) (by psychiatry);  
ABC (by parents); 
Social Adaptive Development 
Quotient Scale (ADQ); 
Parental reported changes in 
children’s behavior, once per 
weak during the intervention; 
OT  in both the control and TEAS groups, but the decrement 
was significantly lower in the TEAS group than that of the 
control; 
AVP  significantly in the TEAS group compared with that in 
the control; 
OXT and AVP showed a positive correlation in the control 
group before any intervention 
Gordon et 
al. (2013) 
To understand 
how changes 
in peripheral 
OT are 
17 children and 
adolescents with 
ASD (18M, 3F) 
Salivary OT 
determined by 
ELISA 
 
Baseline and 30 min 
post-administration 
samples 
 
Reading the Mind in the Eyes Test 
(RMET)  
Positive correlation between changes in salivary OT from 
baseline to 30 min post-administration and activity in the 
amygdala and BA 25 regions during eyes>vehicles; 
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associated 
with changes 
in brain activity 
after 
intranasal OT 
 
(age range: 8–
16.5) 
Salivettes Judgments of social (Eyes) and non-
social (Vehicles) meaningful 
pictures 
Feldman et 
al. (2014) 
 
To assess 1) 
baseline OT in 
pre-schoolers 
with ASD and 
2) test whether 
OT production 
may be 
enhanced by 
parent–child 
contact;  
 
40 pre-schoolers 
with high-
functioning ASD 
(average age of 
5,12 years); 
40 typically 
developed 
controls (matched 
for mental age) 
 
Salivary OT 
determined by 
ELISA  
4 samples for each 
child/parent in different 
time points in relation to 
parental interaction 
 
Baseline collected after 
a period of 
acclimatization; 
 
Salivettes 
Measurements of OT at baseline 
and after synchronous parent-child 
interactions 
Children with ASD had  baseline OT;  
Following 20 min of parent–child interactions, OT 
normalised and remained high during social contact;  
15 min after contact, OT  to baseline.  
OT correlated with parent–child social synchrony in 
both groups.  
Jacobson et 
al. (2014) 
To assess 
baseline OT 
and 
downstream 
cellular 
mediators 
levels in 
autistic 
patients 
37 autistic patients 
(25M, 12F) 
41 typically 
developing 
controls (24M, 
17F) 
(age between 4-6 
years) 
Plasma OT 
levels 
determined by 
ELISA 
(extracted 
samples) 
10 – 12 AM 
2h fasting 
Autism Diagnostic Observation 
Schedule (ADOS) 
 Autism Diagnostic Interview – 
Revised (ADI-R) 
 Developmental Quotient; Kauffman 
Assessment Battery for Children-
Second Edition (KABC-II) 
; Bayley Scales of Infant and Toddler 
Development – Third Edition 
(Bayley-III); 
 Vineland Social-Emotional Early 
Childhood Scales  
 
Males with autism displayed  OT levels compared to 
controls. 
Children with autism displayed significantly  mRNA for 
stimulatory G proteins compared to controls. 
OT levels correlated strongly positively with c-fos mRNA 
levels, but only in control participants 
OT, G-protein, and c-fos mRNA levels correlated inversely 
with measures of social and emotional behaviors, but only in 
control participants.  
 
Fujisawa et 
al. (2014) 
To investigate 
the 
relationship 
between 
visual 
attention to 
social stimuli 
and OT in 
preschool 
ASD children; 
19 ASD children 
(16M, 3F) 
(average age of 
4,8 years) 
60 typically 
developed 
controls (28M, 
32F) (average age 
of 4 years) 
Salivary OT 
determined by 
ELISA 
Salivettes 
2 samples averaged 
Visual attention to 4 categories of 
social stimuli (human faces, people 
and geometry, human motion and 
finger pointing) assessed by eye-
tracking (gaze fixation) 
Positive association between OT and fixation duration for an 
indicated object area in a finger-pointing movie in controls;  
No significant association in ASD children; 
 
Husarova et 
al. (2016) 
To assess 1) 
baseline 
differences in 
plasmatic OT 
levels 
between 
children with 
ASD and 
control healthy 
typically 
19 ASD males  
44 healthy age-
matched males 
(age between 2 – 
9 years) 
Plasma OT 
determined by 
ELISA 
(unextracted 
samples) 
8-9 AM Autistic symptoms evaluated 
through Childhood Autism Rating 
Scale and Autism Diagnostic 
Interview (ADI), adjusted research 
version; Parental autistic traits 
evaluated by Autism Spectrum 
Quotient (AQ), Systemizing Quotient 
(SQ) and Empathizing Quotient  
ASD children had significantly  OT than controls;  
OT positively correlated with ADI Reciprocal Interaction and 
Communication scores; 
 AQ and SQ of fathers positively correlated with children OT; 
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developing 
children; 
2) if plasmatic 
OT levels in 
children with 
autism are 
associated 
with the 
severity of 
particular 
autism 
symptoms and 
autistic traits of 
their parents 
Taurines et 
al. (2014) 
To assess 
baseline 
differences in 
plasma 
concentrations 
of OT in 
children and 
adolescents 
with ASD and 
its relationship 
with ASD 
symptomology 
19 male children 
and adolescents 
with ASD 
19 male children 
with ADHD 
(clinical control 
group) 
17 typically 
developing male 
controls 
(age range 6.0–
17.6 years) 
 
Plasma OT 
determined by 
RIA (extracted 
samples) 
7:30 – 10 AM 
Fasting 
Autism Diagnostic Interview-
Revised (ADI-R)  
Autism Diagnostic Observation 
Schedule (ADOS)  
 
No significant differences in OT between ASD and control 
subjects; 
ASD patients: autistic symptomalogy correlated with OT 
levels; 
ADHD patients present levels of OT significantly  than ASD 
patients; 
 
Abdulamir 
et al. (2016) 
To assess 
baseline 
differences in 
plasma 
concentrations 
of OT in ASD 
patients and 
its relationship 
with ASD 
social and 
cognitive 
dysfunction 
60 male autistic 
patients 
26 age- and 
gender-matched 
control subjects 
(age range 3.0–
13.0 years) 
 
Plasma OT 
determined by 
ELISA 
(unextracted 
samples) 
9 AM 
Overnight fasting 
ASD symptomology grading in 
accordance with DSM - V criteria 
ASD patients present  levels of OT than controls; 
OT associated with disease severity, especially for the most 
severe patients; 
Parker et al. 
(2014) 
To test the 
extent to which 
plasma OT 
concentrations 
and OTR 
SNPs (i) 
interact to 
produce ASD 
phenotypes, 
(ii) exert 
79 children with 
ASD (62M, 17F)  
52 unaffected 
siblings (29M, 
23F) 
62 neurotypical 
control children 
(40M, 22F) 
(age range 3.0–
Plasma OT 
levels were 
quantified by 
ELISA ( 
extracted 
samples) 
Genotyping was 
performed in 
blood DNA for 
the OXTR SNPs 
10 AM – 2 PM Social phenotyping included the 
following instruments: 
Social Responsiveness Scale (SRS) 
"A Developmental 
NEuroPSYchological Assessment" 
(NEPSY-III) 
 
Vineland Adaptive Behavior Scales 
OT not significantly altered between groups, neither in males 
nor in females; 
OT positively predicted theory of mind and social 
communication performance in all groups; 
OT concentrations showed significant heritability between 
ASD-discordant siblings 
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differential 
phenotypic 
effects in ASD 
vs. non-ASD 
children, or (iii) 
have similar 
phenotypic 
effects 
independent 
of disease 
status 
12.0 years) 
 
rs2254298 and 
rs53576 
(VABS-2)  
ADI-R Social Domain Scores 
Miller et al. 
(2013) 
To assess 
baseline 
differences in 
plasma OT in 
male and 
female ASD 
patients and 
its relationship 
with ASD 
social, 
language and 
cognitive 
dysfunction 
75 preadolescent 
and adolescent 
girls and boys; 
40 with high-
functioning ASD 
(21M,19F); 
35 typically 
developing 
children (19M, 
16F) 
(age range 8.0–
18.0 years) 
 
Plasma OT and 
AVP determined 
by ELISA 
(unextracted 
samples) 
Fasting of at least 2h Qualification Measures 
 Wechsler Abbreviated 
Scale of Intelligence 
 Autism Diagnostic 
Observation Schedule 
 Social Communication 
Questionnaire 
 
Autism Symptom Measures 
 
 Social Responsiveness 
Scale 
 Children’s 
Communication Checklist-
2 
 Repetitive Behavior Scale 
 
Internalizing Symptom Measures 
 Behavior Assessment 
System for Children 
Girls showed  levels of OT than boys; Boys showed  levels 
of AVP than girls; 
 
There were no significant effects of diagnosis on OT and AVP 
neither in males nor in females.  
 
 OT values were associated with  anxiety in all girls, and 
with  pragmatic language in all boys and girls. 
 
AVP levels were positively associated with restricted and 
repetitive behaviors in girls with ASD but negatively (non-
significantly) associated with these behaviors in boys with 
ASD; 
Zhang et al. 
(2016) 
To assess 
baseline 
differences in 
plasma OT 
and AVP in 
ASD patients 
and its 
relationship 
with ASD 
social and 
cognitive 
dysfunction 
84 (71M, 13 F) 
ASD children 
85  (71M, 14F), 
age matched, 
typically 
developing 
children 
(age range 2.0–
7.0 years) 
 
Plasma OT and 
AVP determined 
by ELISA 
(extracted 
samples) 
9-11 AM 
Fasting overnight and 
amount of fluids 
minimized 
Autistic symptoms assessed by the 
Childhood Autism Rating Scale 
(CARS) 
Male ASD children present  OT than controls, but no 
significant difference between ASD and control females; 
No significant differences in AVP levels between diagnostic 
groups; 
OT is not correlated between children and their mothers, 
neither in the ASD nor in the control group; 
OT was not correlated with total CARS score, but correlated 
negatively with verbal communication and positively with 
adaptation dimensions of CARS (TRENDS);   
Negative correlation between AVP and object use (TREND) 
Yang et al. 
(2017) 
To assess 
baseline 
differences in 
OT  in ASD 
patients and 
its relationship 
with autistic 
symptoms 
55 ASD children 
(43M, 12F) 
110 (84M, 26F), 
age matched, 
typically 
developing 
children 
(age range 2-17 
years) 
Plasma OT 
determined by 
ELISA 
(extracted 
samples) 
8 – 9:30 AM 
Fasting in the morning 
Autistic symptoms assessed by the 
Childhood Autism Rating Scale 
(CARS) and the Autism Behavior 
Checklist (ABC) 
ASD subjects exhibited  OT than controls;  
Positive correlations between OT levels and “adaptation to 
change score” and CARS total scores; 
ASD subjects: OTR SNP rs2254298 genotype was associated 
with serum OT levels (G-carriers>AA); 
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Tsuji et al 
(2015) 
To assess the 
impact of 
maternal 
massage 
therapy on 
salivary OT 
levels of 
autistic 
children  
7 ASD males 
(age range 8-12 
years) 
Salivary OT 
measured by 
ELISA  
Paper cups 
 
Baseline and post-
massage samples 
collected after a period 
of free playing 
Maternal massage During the period of massage therapy, the children and 
mothers exhibited  OT than during the non-massage period; 
OT before and after a single massage session was not 
significantly changed neither in children nor in mothers;  
 
Corbet et al 
(2016) 
To evaluate 
the 
relationship 
between 
cortisol and 
OT/AVP in 
children with 
ASD under 
baseline and 
physiological 
stress 
(hydrocortison
e challenge) 
conditions 
14 ASD (12M, 2F) 
(average age 9,70 
years) 
11 Neurotypical 
controls (10M,1F) 
(average age 
9,37) 
Salivary and 
plasma OT and 
AVP measured 
by ELISA 
(unextracted 
samples) 
1 – 4 PM 
 
Baseline collected after 
acclimatization to the 
experimental setting 
Autism Diagnostic Observation 
Schedule (ADOS) 
Wechsler Abbreviated Scale of 
Intelligence (WASI) 
Social Communication 
Questionnaire (SCQ) 
Social Responsiveness Scale (SRS) 
No differences in baseline OT and AVP salivary and plasma 
levels between ASD and controls; 
Controls: OT  during physiological challenge and remained 
stable or  during placebo administration; 
ASD: OT remained stable or  during both the physiological 
challenge and the placebo condition; 
No significant effects of challenge on AVP levels, neither in 
controls nor ASD; 
In the TD group, the SRS was positively associated with 
baseline AVP; 
In the ASD group, there was a modest negative correlation 
between SRS and AVP at baseline (TREND); 
Shou et al 
(2017) 
To investigate 
the 
relationship 
between 
autistic 
behaviours, 
circulating 
AVP and the 
structure and 
functional 
connectivity 
(FC) of 
specific brain 
regions in 
autistic 
children 
compared with 
typically 
developing 
children 
14 ASD (12M, 2F) 
14 neurotypical 
controls (10M, 4F) 
(age range 3-5 
years) 
Plasma AVP 
measurements 
by ELISA 
(extracted 
samples) 
8-10:30 AM 
 
No more than 7 days 
after MRI 
 
Overnight fasting + fluid 
intake minimized 
Childhood Autism Rating Scale 
The Autism Behavior Checklist 
(ABC) 
The Autism Spectrum Quotient 
Children’s Version (AQChild) 
AVP negatively correlated with the visual and listening 
response score in CARS 
AVP positively correlated with the total volume of the 
hypothalamus 
In boys with ASD: positive correlation between the functional 
connectivity of the left amygdala-supramarginal gyrus and 
AVP; 
Carson et al 
(2015) 
To test 
whether blood 
AVP 
concentrations 
1) differed 
between 
children with 
ASD, their 
ASD 
discordant 
siblings, and 
neurotypical 
57 ASD (48M, 9F) 
47 ASD discordant 
siblings (27M, 
20F) 
55 neurotypical 
controls (36M, 
19F) 
(age range 3-12 
years) 
Plasma AVP 
measurements 
by ELISA 
(extracted 
samples) 
Study 1: Samples taken 
at morning or afternoon 
or night; CSF samples 
taken from the cisterna 
magna orleft ventricle or 
lumbar puncture; local 
or general anaesthesia 
applied; 
 
Study 2: 10 AM – 2 PM  
NEPSY-II Social and Perception 
Domain: Affect Recognition and 
Theory of Mind tasks 
Social Responsiveness Scale (SRS) 
AVP did not differ by group or sex; 
No relationship between AVP and Theory of Mind score in 
non-ASD children;  
AVP positively predicted Theory of Mind score in children with 
ASD;  
AVP did not predict Affect Recognition score or SRS Total 
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controls; and 
2) predicted 
social 
functioning 
Oznan et al 
(2018) 
To test the 
ablity of a 
multidimensio
nal biomarker 
based on OT 
and AVP and 
their receptors 
quantification 
to predict 
diagnosis 
status 
44 ASD (37M, 7F) 
(age range 6-12) 
Plasma OT and 
AVP 
measurements 
by ELISA 
(extracted 
samples) 
OXTR and 
V1aR 
expression 
quantified in 
huma 
lymphocytes by 
qPCR 
10 AM – 5 PM 
Within 2 weeks of 
behavioural 
phenotyping 
The core behavioral features of 
ASD (i.e., social impairments and 
restricted, repetitive behaviors) 
were assessed using the Social 
responsiveness scale and the 
Repetitive Behavioural scale. 
 
ASD patents do not differ from controls in AVP or OT blood 
levels, but present  levels of total neuropeptides receptor 
expression (sum of the OXTR and AVPR1A gene expression.  
 levels of total neuropeptide receptor gene expression and 
plasmatic OT (when included in a model considering 
receptors expression, plasmatic OT predicted disease 
status). 
Levels of AVP do not predict disease status. 
 levels of total neuropeptide receptor gene expression 
predicted  social impairments as measured by the SRS 
total score and  severity of stereotipy 
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Table 6.2) Clinical samples (others)    
Study Aim Sample Method of 
OT/AVP 
measurement 
Biological sample collection Social measures Results 
Swedo et al. 
(1992) 
To study CSF 
OT/AVP levels 
in children and 
adolescents 
with OCD; 
43 children and 
adolescents with 
primary OCD 
(26M, 17F) 
(age range 6-19 
years) 
Lumbar CSF 
OT/AVP levels 
determined by RIA 
(extracted 
samples) 
9 – 10:30 AM 
 
Lumbar puncture 
 
Medication free for a minimum of 
4 weeks and low monoamine diet 
for 3 days 
 
 
Hamilton Depression Rating 
Scale 
NMH Global Scales for OCD, 
depression, anxiety, and 
overall functioning; 
AVP was negatively correlated with several 
ratings of obsessive-compulsive disorder 
symptom severity; 
AVP was  in a subgroup of patients with 
checking rituals; OT did not differ between 
subgroups;  
OT was positively correlated with depressive 
symptoms;  
The ratio AVP/OT was negatively correlated with 
obsessive-compulsive and depressive 
symptoms; 
Comorbid affective disorder was associated with 
 AVP;  
Anxiety disorder was associated with  OT; 
OT was  in a subgroup of patients who did not 
have family history than in patients with a 
positive family history; 
Demirci et al. 
(2016)a 
To determine 
the 
relationship 
between OT 
levels and 
impulsivity in 
both healthy 
controls and 
ADHD 
patients; 
40 male ADHD 
patients 
40 male age 
matched 
controls 
(age range 8-15 
years) 
Plasma OT 
measured by 
ELISA 
(unextracted 
samples) 
8 AM 
 
Overnight fasting 
Turgay DSM-IV-based Child and 
Adolescent Behavior Disorders 
Screening and Rating scale: 
Barrrat Impulsiveness Scale-11 
(BIS-11) 
OT was  in the ADHD group than in controls; 
 
OT negatively correlated with impulsivity and attention 
subscale scores of BIS-11 in both groups; 
Demirci et al. 
(2016)b 
To determine 
the 
relationship 
between 
aggression, 
empathy and 
OT levels in 
children and 
adolescents 
with ADHD; 
40 male ADHD 
patients 
40 male age 
matched 
controls 
(age range 7-18 
years) 
Plasma OT 
measured by 
ELISA 
(unextracted 
samples) 
8-9 AM 
 
Overnight fasting 
 
Rest period of 25 mins 
Buss–Perry Aggression 
Questionnaire  
Bryant’s Empathy Index 
(BEI) for 
Children and Adolescents 
Reading the Mind in the Eyes 
test (RMET) 
ADHD patients presenedt  OT; 
Patients with a hyperactive/impulsive subtype of 
disease presented  OT than the inattentive 
subtype; 
Negative correlation between OT and 
aggression scores in the ADHD patients, but not 
in controls; 
Positive correlation between OT and RMET 
scores in both patients with ADHD and controls 
(in children but not adolescents); 
Positive correlation between the BEI and OT in 
patients but not in controls; 
Lebowitz et 
al. (2017) 
To evaluate 
OT’s 
response 
during 
youth-
mother 
interaction 
in clinically 
anxious 
youth 
41 clinically 
anxious youth 
(14M, 27F), 
(age range 7–
16 years)  
Salivary OT 
measurements 
through ELISA 
(unextracted)  
 
4 – 5 PM 
 
2h fasting 
Anxiety disorders interview 
schedule—Children and 
parent (ADIS-C/P) 
Multidimensional anxiety 
scale for children (MASC2) 
Dyadic interaction: subjective 
coding and evaluation through 
the application of the Coding 
Interactive Behaviour (CIB) 
system  
Affective touch, maternal sensitivity, maternal 
intrusiveness, youth engagement and youth 
initiative predicted youth’s OT response; 
When affective touch was high, youth had  OT 
response; 
OT response to a positive youth–mother 
interaction is  among youth with Separation 
anxiety disorder (SAD), compared to clinically 
anxious youth without SAD; 
Sasaki et al 
(2016) 
To determine 
whether 
serum levels 
of OT in 
10 TRDIA (6M, 
4F) (average 
age 14,40 
years) 
Serum OT 
measurements 
through ELISA 
10 AM – 3 PM Children’s Depression 
Rating Scale-Revised 
(CDRS-R)  
TRDIA patients present  OT than non-TRDIA 
and controls; 
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 treatment-
resistant 
depression in 
adolescents 
(TRDIA) differ 
from non-
treatment-
resistant 
depression 
(non-TRDIA) 
or controls. 
27 non-TRDIA 
(11M, 16F) 
(average age 
12.89 years) 
25 neurotypical 
controls (12M, 
13F) (average 
age 12,88 
years) 
(extracted 
samples) 
 
Depression Self-Rating Scale 
for Children-Japanese 
Version (DSRS-C-J) 
No significant correlation between OT and the 
CDRS-R total scores or DSRS-C-J scores in any 
group; 
No differences in OT between the medicated 
group with adolescent depression and non-
medicated group with adolescent depression; 
Levy et al 
(2015) 
To examine 
the 
relationship 
between OT 
and conduct 
problems 
(specifically 
callous-
unemotional 
traits) 
67 M adolescent 
undergoing 
residential 
treatment 
(age range 15-
19 years) 
Saliva OT levels 
measured by 
ELISA 
Late noon 
 
Salivettes 
Eating, drinking, smoking and oral 
hygiene resfrained 
 
Sample collected before 
questionnaires 
Inventory of 
callous-unemotional traits  
Strengths and difficulties 
questionnaire 
Brown Goodwin 
Questionnaire (BGQ) 
OT inversely correlated with conduct problems 
severity on Strength and Difficulties 
Questionnaire; 
Recorded history of antisocial acts did not 
correlate with current OT;  
 odds ratio for significant CU traits among 
subjects with conduct problems in low-OT vs 
high-OT subjects; 
 
Bilgiç et al 
(2016) 
to investigate 
whether 
serum levels 
of AVP  in 
children with 
ADHD differ 
from those of 
sex- and age-
matched 
healthy 
controls 
24 ADHD (24M, 
10F) 
36 controls 
(23M, 13F) 
(age range 7-15 
years) 
Plasma AVP 
levels measured 
by ELISA 
(unextracted 
samples) 
8 – 10 AM 
 
Overnight fasting 
CPRS-RS (Conners’ Parent 
Rating Scale-Revised 
Short); CTRS-RS 
(Conners’ Teacher 
Rating Scale-Revised 
Short) 
No significant differences between ADHD 
patients and controls in AVP, neither in males 
nor females; 
Johnson et al. 
(2016) 
To assess 
baseline 
differences in 
plasma 
concentration
s of OT 
between PWS 
patients and 
controls 
23 PWS children 
with  
genetic 
confirmation 
(13M, 10F) 
18 age matched 
healthy 
unrelated 
siblings without 
PWS (10M, 8F) 
(age range 5.0–
11.0 years) 
 
Plasma levels of 
OT determined by 
immunoassay 
 
Morning  
 
Overnight fasting 
 
PWS patients under weight 
control program 
PWS diagnosis  OT levels in children with PWS compared with 
unrelated and unaffected siblings without the 
diagnosis of PWS; 
The diagnosis of PWS predicted OT’s level in 
controlled regression analysis; 
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